France· FR:69260153
ISENTRESS 100 mg, granulés pour suspension buvable
A medicinal product containing raltégravir potassique, registered in France by MERCK SHARP & DOHME (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RALTÉGRAVIR POTASSIQUE
- Manufacturer
- MERCK SHARP & DOHME (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092794636360 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) avec 2 seringue(s) doseuse(s)EUR 197.16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Raltégravir potassique in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandISENTRESSMerck Sharp & Dohme B.V.
- PolandIsentressMerck Sharp & Dohme B.V.
- United StatesISENTRESSMerck Sharp & Dohme LLC
- United KingdomIsentress 100mg chewable tabletsMerck Sharp & Dohme (UK) Ltd
- NetherlandsIsentress 100 mg kauwtablettenMerck Sharp & Dohme B.V.
- CzechiaISENTRESSMerck Sharp & Dohme B.V., Haarlem
- SpainISENTRESS 100 MG COMPRIMIDOS MASTICABLESMerck Sharp & Dohme B.V.
- IcelandIsentressMerck Sharp & Dohme B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
- Cyprus · Raltegravir Viatris
- Germany · Raltegravir Axiromed, Raltegravir Beta
- Denmark · Raltegravir Viatris, Raltegravir Zentiva
- Estonia · Raltegravir Viatris, Raltegravir Zentiva
- Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
- Finland · Raltegravir Viatris, Raltegravir Zentiva
- United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
- Greece · Ralpecin, Raltegravir Viatris
- Croatia · Raltegravir Viatris
- Iceland · Isentress, Raltegravir Zentiva
- Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
- Liechtenstein · Isentress
- Lithuania · Raltegravir Zentiva
- Latvia · Raltegravir Viatris, Raltegravir Zentiva
- Malta · Raltegravir Viatris
- Netherlands · Raltegravir Rockmed Pharma, Raltegravir Viatris
- Norway · Isentress, Raltegravir Viatris
- Poland · Raltegravir Viatris
- Portugal · Raltegravir Mylan, Raltegravir Zentiva
- Romania · Raltegravir Viatris, Raltegravir Zentiva
- Sweden · Raltegravir Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efa83264-da39-4690-a1b7-1004ced2b1fc GET /v1/drugs/efa83264-da39-4690-a1b7-1004ced2b1fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69260153",
"date_amm": "2014-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/436",
"substance": "RALTÉGRAVIR POTASSIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granulés pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about raltégravir potassique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.